|Articles|January 1, 2019
- BioPharm International-01-01-2019
- Volume 32
- Issue 1
BioPharm International, January 2019 Issue (PDF)
Click the title above to open the BioPharm International January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Internal and External Challenges to Biopharma in 2019about 7 years ago
Matching Personal and Company Successabout 7 years ago
Identifying Incentives to Adopt Advanced Manufacturingabout 7 years ago
Modeling the Degradation of mAb Therapeuticsabout 7 years ago
A Look at the Affinity Chromatography Landscapeabout 7 years ago
The Role of Automation in Cell-Line Developmentabout 7 years ago
CDER Priorities for 2019: Opioids, Quality, Safety, and Innovationabout 7 years ago
Global Inspection Harmonizationabout 7 years ago
The Outlook for CMO Outsourcing in 2019Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4